WEBINAR | Advancing Global Risk Management and REMS Through Innovation and Measurable Outcomes
As regulatory expectations evolve, biopharmaceutical organizations face growing pressure to demonstrate the effectiveness of global risk management and Risk Evaluation and Mitigation Strategies (REMS) programs. Success requires more than regulatory compliance. It demands stronger patient and healthcare provider engagement, effective governance and measurable outcomes.
Drawing on key insights from the 2026 World Patient Safety Europe and World Patient Safety Americas conferences, this webinar explores emerging trends and practical approaches shaping the future of risk minimization across global markets.
Watch the webinar replay to explore:
- Evolving regulatory expectations for global risk management and REMS programs
- Emerging trends in benefit-risk management and risk minimization strategies
- Approaches to measuring healthcare provider knowledge and behavior
- The role of digital innovation and patient engagement in improving program effectiveness
- Governance and operational models that support consistent global implementation
Discover how organizations are adapting their strategies, leveraging technology and strengthening measurement to advance more effective, patient-focused risk management programs worldwide.
Related Content
Looking for exclusive insight?
